文献速递抗栓抗凝管理治疗药物监测与药物基因组学

延长INR随访间隔对稳定华法林剂量退伍军人医疗使用的影响

Impact of an extended International Normalized Ratio follow-up interval on healthcare use among veteran patients on stable warfarin doses.
PubMed 文献 · Am J Health Syst Pharm · 2019-01-01

在药师管理的抗凝门诊中开展前瞻性队列研究,对稳定华法林剂量的退伍军人逐步将INR随访间隔延长至12周。结果显示12个月时计划抗凝就诊平均减少2.24次(p<0.001),12至24个月时计划就诊减少3.13次(p<0.001)但非计划就诊增加0.54次(p=0.04),其余医疗使用指标无显著差异。

要点

  • 稳定华法林剂量患者延长INR随访至12周可减少计划抗凝就诊次数。
  • 延长间隔未增加急诊就诊或住院等急性医疗使用。
  • 需权衡安全性、有效性与可行性后再实施该策略。

核心结论

  • 延长INR随访间隔似乎可减少抗凝相关医疗使用而不增加急性医疗使用。
  • 该干预可能具有成本效益,但机构实施前需考虑安全性、有效性和可行性。

研究设计与样本

  • 前瞻性队列研究,在药师管理的抗凝门诊开展,为期2年。
  • 采用详细方案将INR随访间隔逐步延长至5-6周、7-8周和11-12周。
  • 收集计划与非计划抗凝就诊、需中断华法林的操作、电话分诊来电、急诊就诊和住院等数据。
  • 对连续4次安排12周间隔的参与者进行事后亚组分析。

主要发现

  • 12个月时44名参与者计划抗凝就诊平均减少2.24次(p<0.001)。
  • 12至24个月时39名参与者计划抗凝就诊平均减少3.13次(p<0.001),非计划抗凝就诊平均增加0.54次(p=0.04)。
  • 其余医疗使用变量在任何时间点与基线相比均无统计学显著差异。
  • 15名连续4次安排12周间隔的参与者一年内就诊较基线减少约5次(p<0.001)。

临床怎么用

  • 对稳定华法林剂量的退伍军人患者可考虑逐步延长INR随访间隔至12周。
  • 实施前应评估本机构的安全监测能力与患者依从性。

局限性

  • 研究为单中心药师管理抗凝门诊的前瞻性队列,样本量较小。
  • 部分分析为事后亚组分析,结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To analyze the impact of a 12-week extended International Normalized Ratio (INR) follow-up interval on healthcare use. METHODS: A prospective cohort study of the use of an extended INR follow-up interval of up to 12 weeks was conducted over 2 years in a pharmacist-managed anticoagulation clinic. A detailed protocol was used to extend the INR follow-up interval to 5-6 weeks and then 7-8 weeks and 11-12 weeks. The number of planned and unplanned anticoagulation encounters, procedures requiring warfarin interruption, telephone triage phone calls, emergency department visits, and hospitalizations were collected. A post hoc subanalysis was also completed on participants who were scheduled for 4 consecutive 12-week intervals. RESULTS: Compared to baseline, at 12 months there was a mean decrease in planned anticoagulation encounters of 2.24 visits (p < 0.001) among 44 participants. From 12 to 24 months compared to baseline, there was a mean decrease in planned anticoagulation encounters of 3.13 visits (p < 0.001) and an increase of 0.54 unplanned anticoagulation encounters (p = 0.04) among 39 participants. The remainder of healthcare use variables were not statistically significantly different from baseline at any time point. Of the 15 participants scheduled for 4 consecutive 12-week intervals, there was a decrease from baseline of approximately 5 visits over the course of a year (p < 0.001). CONCLUSION: An extended INR follow-up interval appears to decrease anticoagulation healthcare use without an increase in acute healthcare use. While this intervention could be cost-effective, institutions need to consider safety, efficacy, and feasibility prior to implementation.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Margolis AR, Porter AL, Staresinic CE, et al. Impact of an extended International Normalized Ratio follow-up interval on healthcare use among veteran patients on stable warfarin doses. Am J Health Syst Pharm. 2019. PMID: 31589272. doi:10.1093/ajhp/zxz209

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。